Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
The Prostate-Specific Antigen (PSA) assay is an in vitro diagnostic device used to measure PSA levels in blood serum, used as an aid in the management and monitoring of prostate cancer, including detection of recurrence and response to therapy. It is classified as a Class 2 (moderate risk) device, subject to general and special controls, and requires 510(k) premarket notification. The product code is LTJ, regulated under 21 CFR 866.6010, within the Immunology medical specialty. This device is eligible for third-party review under the FDA's accredited persons program.
Research product code LTJ in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- LTJ
- Device Class
- FDA class 2
- Regulation Number
- 866.6010
- Medical Specialty
- Immunology
- Review Panel
- IM
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 34 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K251630 | Atellica IM Total PSA II (tPSAII) | Jan 05, 2026 | Substantially Equivalent | Siemens Healthcare Diagnostics, Inc. |
| K162378 | FREND PSA PLUS (reagent cartridge) | May 17, 2017 | Substantially Equivalent | Nanoentek USA, Inc. |
| K124056 | FREND PSA PLUS (REAGENT CARTRIDGE) | May 29, 2013 | Substantially Equivalent | Nanoentek, Inc. |
| K031343 | TPSA FLEX REAGENT CARTRIDGE | May 15, 2003 | Substantially Equivalent | Dade Behring, Inc. |
| K022288 | COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM | Dec 17, 2002 | Substantially Equivalent | Bayer Corp. |
| K022177 | PROSTATE SPECIFIC ANTIGEN (PSA) ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM | Dec 17, 2002 | Substantially Equivalent | Bayer Diagnostics Corp. |
| K010550 | VIDAS TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA), MODEL 30 428 | Apr 24, 2001 | Substantially Equivalent | bioMerieux, Inc. |
| K003963 | DIMENSION PSA FLEX REAGENT CARTRIDGE | Feb 28, 2001 | Substantially Equivalent | Dade Behring, Inc. |
| K002376 | ADVIA: CENTAUR AND ACS: 180 CPSA ASSAY | Oct 26, 2000 | Substantially Equivalent | Bayer Corp. |
| K003094 | FASTPACK PSA IMMUNOASSAY, FASTPACK ANALYZER | Oct 25, 2000 | Substantially Equivalent | Qualigen, Inc. |
| K002313 | COMPLEXED PSA MICROTITER ELISA | Aug 30, 2000 | Substantially Equivalent | Oncogene Science, Inc. |
| K002121 | TOTAL PSA MICROTITER ELISA | Aug 30, 2000 | Substantially Equivalent | Oncogene Science, Inc. |
| K994419 | FASTPACK PSA IMMUNOASSAY, FASTPACK SYSTEM | Jun 28, 2000 | Substantially Equivalent | Qualisys Diagnostics, Inc. |
| K994221 | BAYER PSA ASSAY | Apr 13, 2000 | Substantially Equivalent | Bayer Corp. |
| K000566 | MODOFICATION TO VITRO IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT PACK, VITRO IMMUNODIAGNOSTIC PRODUCTS PSA CALIBRATORS | Mar 09, 2000 | Substantially Equivalent | Ortho-Clinical Diagnostics, Inc. |
| K990234 | QUALISYS PSA IMMUNOASSAY | Jul 08, 1999 | Substantially Equivalent | Qualisys Diagnostics, Inc. |
| K984289 | VITROS IMMUNODIAGNOSTIC PRODUCTS PSA CALIBRATORS, VITROS IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT PACK | Mar 12, 1999 | Substantially Equivalent | Ortho-Clinical Diagnostics, Inc. |
| K982949 | ELECSYS PSA, MODEL 2010 | Oct 27, 1998 | Substantially Equivalent | Boehringer Mannheim Corp. |
| K982948 | ELECSYS PSA, MODEL # ELECSYS 1010 | Oct 27, 1998 | Substantially Equivalent | Boehringer Mannheim Corp. |
| K981634 | BIOCIRCUITS IOS PROSTATE SPECIFIC ANTIGEN (PSA) TEST CARTRIDGES, BIOCIRCUITS IOS PSA CONTROLS | Oct 13, 1998 | Substantially Equivalent | Biocircuits Corp. |
| K981839 | ACS:CENTAUR PSA2 IMMUNOASSAY | Aug 12, 1998 | Substantially Equivalent | Chiron Diagnostics Corp. |
| K973244 | ACTIVE PSA IRMA (DSL-9700) | Aug 03, 1998 | Substantially Equivalent | Diagnostic Systems Laboratories, Inc. |
| K973243 | ACTIVE PSA ELISA (DSL-10-9700) | Aug 03, 1998 | Substantially Equivalent | Diagnostic Systems Laboratories, Inc. |
| K980376 | THE COMPLEXED PSA ASSAY FOR THE BAYER IMMUNO 1 SYSTEM | Apr 23, 1998 | Substantially Equivalent | Bayer Corp. |
| K974842 | IMMULITE 2000 3RD GENERATION PSA | Apr 21, 1998 | Substantially Equivalent | Diagnostic Products Corp. |
| K980716 | ADVANTAGE CHEMILUMINESCENCE PROSTATE SPECIFIC ANTIGEN (PSA) IMMUNOASSAY | Apr 03, 1998 | Substantially Equivalent | Nichols Institute Diagnostics |
| K974816 | ACCESS(R) PSA REAGENTS ON THE ACCESS(R) IMMUNOASSAY ANALYZER 33220, 33225, 33229 | Feb 20, 1998 | Substantially Equivalent | Beckman Instruments, Inc. |
| K974189 | ELECSYS PSA (ON ELECSYS 1010) | Jan 06, 1998 | Substantially Equivalent | Boehringer Mannheim Corp. |
| K972021 | IMMULITE THIRD GENERATION PSA (LKUPI,LKUP5) | Oct 31, 1997 | Substantially Equivalent | Diagnostic Products Corp. |
| K973101 | PROSTATE SPECIFIC ANTIGEN METHOD | Sep 18, 1997 | Substantially Equivalent | Dade Chemistry Systems, Inc. |
| K972095 | IMMULITE 2000 PSA | Aug 22, 1997 | Substantially Equivalent | Diagnostic Products Corp. |
| K964351 | ELECSYS PSA ASSAY | Jul 25, 1997 | Substantially Equivalent | Boehringer Mannheim Corp. |
| K964595 | OPUS PSA TEST SYSTEM | Jun 24, 1997 | Substantially Equivalent | Behring Diagnostics, Inc. |
| K965085 | ENZYMUN-TEST PSA | Mar 19, 1997 | Substantially Equivalent | Boehringer Mannheim Corp. |
FEI Numbers
This FDA classification entry is associated with 32 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 32 registration numbers. Click on an entry to view related FDA registrations.